Virus Diseases and Respiratory Tract Diseases

At Vee Perearstikeskus OÜ in Paide, Estonia, clinical research in these areas focuses on common respiratory and viral illnesses, especially influenza and respiratory syncytial virus infections. The trials are designed to assess the safety, immune response, and overall effectiveness of new vaccine candidates and related preventive approaches.

  • Studying a new influenza vaccine to see how well it protects against seasonal flu
  • Evaluating immune responses to RSV vaccination in older adults
  • Assessing the safety and tolerability of preventive vaccines for viral respiratory disease

This work supports better protection against infections that can cause significant illness in both older adults and vulnerable populations.

Bacterial Infections and Mycoses

Research in bacterial infections at this site centers on pneumococcal immunization and the prevention of disease caused by Streptococcus pneumoniae. The studies aim to compare vaccine responses, confirm protection across age groups, and further evaluate safety in infants, toddlers, children, and adolescents.

  • Testing a pneumococcal conjugate vaccine for immune protection in young children
  • Comparing vaccine performance across different age groups to support broader use
  • Monitoring safety and immune response after catch-up vaccination

These trials help advance vaccination strategies against a major bacterial cause of respiratory and invasive disease.

Virus Diseases and Bacterial Infections and Mycoses

The site also contributes to vaccine research for childhood and adolescent prevention, including varicella and pneumococcal immunization. These studies are focused on confirming that vaccine lots are consistent, safe, and capable of producing a strong immune response.

  • Evaluating a chickenpox vaccine for immune response and safety in healthy children
  • Checking consistency between vaccine manufacturing lots
  • Comparing investigational vaccines with established options to support prevention

Overall, the research supports reliable immunization programs aimed at reducing preventable infectious diseases across pediatric populations.